References | Country | Type | Level of evidence | Study quality | NOS Scale | ||||
---|---|---|---|---|---|---|---|---|---|
Downs and Black Score | Selection | Comparability | Expose | Outcome | Total score | ||||
Song et al. [21] | Korea | Cohort study | III | 16 | *** | ** | – | ** | ******* |
Manzotti et al. [12] | Italy | Case–control study | II | 21 | *** | ** | ** | – | ******* |
Valenzuela et al. [37] | USA | Case–control study | II | 17 | *** | ** | * | – | ****** |
Weber et al. [17] | Austria | Case–control study | II | 23 | ** | * | ** | – | ****** |
Konyves et al. [20] | Australia | Case–control study | II | 19 | *** | ** | ** | – | ******* |
Jung et al. [13] | Korea | Cohort study | III | 20 | *** | ** | – | ** | ******* |
Rosenberger et al. [10] | Austria | Case–control study | II | 16 | *** | ** | ** | – | ******* |
Jenny et al. [33] | South-Korea | Case–control study | II | 16 | ** | ** | ** | – | ****** |
Keene et al. [34] | France | Cohort study | III | 17 | *** | * | – | ** | ****** |
Perlick et al. [36] | Australia | Cohort study | II | 18 | *** | ** | – | * | ****** |
Cossey and Spriggins [32] | Denmark | Cohort study | II | 19 | *** | * | – | ** | ****** |
Jenny and Boeri [15] | UK | Case–control study | III | 18 | *** | ** | ** | – | ******* |